BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9333990)

  • 41. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of methadone in the treatment of narcotic addiction].
    Tiljak H
    Lijec Vjesn; 1998 May; 120(5):125-31. PubMed ID: 9748791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation].
    Kornør H; Waal H
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):332-4. PubMed ID: 14963504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
    Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
    Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
    Langleben DD; Ruparel K; Elman I; Busch-Winokur S; Pratiwadi R; Loughead J; O'Brien CP; Childress AR
    Am J Psychiatry; 2008 Mar; 165(3):390-4. PubMed ID: 18056224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [How do the substitution programs help in social integration of drug addicts?].
    Déglon JJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():100-1. PubMed ID: 7880004
    [No Abstract]   [Full Text] [Related]  

  • 50. [Are substitution practices indicated in withdrawal within the framework of health care of drug addicts and according to what modalities?].
    Lauzon P
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():87-8. PubMed ID: 7880036
    [No Abstract]   [Full Text] [Related]  

  • 51. [Reply concerning the article "Is methadone maintenance provided by private practitioners effective?' by R. Stohler et al. in SPM 49 (2004), 276-80].
    Meili D; Dober S
    Soz Praventivmed; 2005; 50(1):7-9; author reply 10-1. PubMed ID: 15771322
    [No Abstract]   [Full Text] [Related]  

  • 52. General practitioners and opiate-abusing patients.
    McKeganey NP; Boddy FA
    J R Coll Gen Pract; 1988 Feb; 38(307):73-5. PubMed ID: 3204571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The general practitioner and drug dependence.
    Paul AH
    N Z Med J; 1972 Oct; 76(485):278-9. PubMed ID: 4509220
    [No Abstract]   [Full Text] [Related]  

  • 54. Brokerage model rehabilitation system for opiate dependence: a behavioral analysis.
    Thompson T; Koerner J; Grabowski J
    NIDA Res Monogr; 1984; 46():131-46. PubMed ID: 6427620
    [No Abstract]   [Full Text] [Related]  

  • 55. [Drug withdrawal under anesthesia--an alternative to substitution therapy. Model project in a Bavarian district hospital. Interview by Dr. rer. nat. Anita Schweiger].
    Reiss J
    Fortschr Med; 1996 Aug; 114(24):12-3. PubMed ID: 8974965
    [No Abstract]   [Full Text] [Related]  

  • 56. Heroin addiction: what can the GP do?
    Manzie PP
    Aust Fam Physician; 1978 Oct; 7(10):1233-40. PubMed ID: 736836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Problem drug users: a problem for the GP?
    Cohen J
    Practitioner; 1994 Oct; 238(1543):715-8. PubMed ID: 7991487
    [No Abstract]   [Full Text] [Related]  

  • 58. [Reflections apropos of methadone: posology and use in the United States].
    Newman RG
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():89. PubMed ID: 7880037
    [No Abstract]   [Full Text] [Related]  

  • 59. Care of drug misusers.
    Coombs DM
    Br J Gen Pract; 1993 Apr; 43(369):176. PubMed ID: 8323813
    [No Abstract]   [Full Text] [Related]  

  • 60. Estimating incidence trends in regular heroin use in 26 regions of Switzerland using methadone treatment data.
    Nordt C; Landolt K; Stohler R
    Subst Abuse Treat Prev Policy; 2009 Jun; 4():14. PubMed ID: 19519920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.